SCHEMBL23875271

SCHEMBL23875271

O=C(I)c1ccc(N2CCN(CC3CCNCC3)CC2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGDS O60760 4/20 0.46
CACNA2D1 P54289 1/20 0.43
CACNA1B Q00975 1/20 0.43
CACNB1 Q02641 1/20 0.43
HTR1A P08908 2/20 0.40
DRD2 P14416 2/20 0.40
DRD4 P21917 2/20 0.40
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR7 P34969 2/20 0.40
DRD3 P35462 2/20 0.40
TMEM97 Q5BJF2 2/20 0.40
SIGMAR1 Q99720 2/20 0.40
OPRM1 P35372 1/20 0.40
OPRK1 P41145 1/20 0.40
CHRM4 P08173 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
ALDH1A1 P00352 2/20 0.38
PARP1 P09874 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23867171 0.85 KDM4E (0.46) HPGDSHTR1ADRD2DRD4HTR2A
SCHEMBL20322499 0.83 CHRM4 (0.40) HPGDSHTR1ADRD2DRD4HTR2A
Trifluoroacetic Acid SCHEMBL30349693 0.82 OPRM1 (0.48) HPGDSCACNA2D1CACNA1BCACNB1OPRM1
SCHEMBL19600790 0.80 HPGDS (0.50) HPGDSDRD2HTR2ADRD3ALDH1A1
SCHEMBL27366890 0.79 DRD2 (0.46) CACNA2D1CACNA1BCACNB1HTR1ADRD2
SCHEMBL27366339 0.76 PDE10A (0.47) CACNA2D1CACNA1BCACNB1HTR1ADRD2
SCHEMBL23594261 0.75 KDM2B (0.47) CACNA2D1CACNA1BCACNB1HRH3ALDH1A1
SCHEMBL24003534 0.74 ALDH1A1 (0.47) HPGDSHRH3ALDH1A1NPC1RAB9A
SCHEMBL30863341 0.74 GPR119 (0.41) CACNA2D1CACNA1BCACNB1DRD2HTR2A
SCHEMBL24003533 0.74 ALDH1A1 (0.49) HTR1ADRD2DRD4HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021194878-A1 SELECTIVE MODULATORS OF MUTANT LRRK2 PROTEOLYSIS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2021-09-30 WO disclosed